MAVENIR
10.1.2022 09:02:11 CET | Business Wire | Press release
Mavenir, the Network Software Provider building the future of networks with cloud-native software that runs on any cloud and transforms the way the world connects, today announced that BAI Communications (BAI), a global communications infrastructure provider, will be launching a Smart City project for Sunderland City Council in the north of England (UK), powered by Mavenir’s MAVedge solution.
BAI Communications will build a new 5G centric network to accelerate adoption of transformative digital services for sectors including manufacturing and logistics, education and social care. The initial scope is for the deployment of a city-centre 5G private network which has the potential to evolve and become a neutral host network.
Neutral host models provide coverage and connectivity for smart city initiatives. They enable local councils and authorities to provide smart services and run numerous smart community applications in a more viable and cost-effective manner.
MAVedge comprises Mavenir’s leading edge Open vRAN and 5G Packet Core solutions to drive the next generation digital transformation of this Smart City project, and to provide advanced 5G mobile connectivity to the local Sunderland community. MAVedge enables secure private networks to be distributed at the edge and powers a digital marketplace of applications and devices to create an efficient environment for diverse use cases for the enterprise and industry.
The 5G Open vRAN and 5G Packet Core solutions are designed with cloud-native virtualisation techniques providing a fully scalable and virtualised network architecture with open standard interfaces. The Open RAN platform provides BAI Communications the option of deploying radio units from different vendors. The solution uses software running on commercial off the shelf (COTS) hardware that provides cost effectiveness, flexibility and agility, whilst delivering one architecture as a baseline for many different use cases.
The new network will help accelerate transformation within various sectors in Sunderland including:
- Smart Homes: addressing health and social care requirements supporting vulnerable individuals living in their own homes, providing access to assistive technologies such as sensors and other IoT enabled devices.
- Digital Skills and Education: providing enhanced online and remote connectivity and distance learning across Primary Schools and Secondary Schools within the local authority.
- Manufacturing and Industry 4.0: improving supply chain agility for the automotive industry, including applications such as self-driving vehicles and autonomous heavy goods vehicles.
“Open RAN is a cost-effective solution which is based on open interfaces and will give us the ability to deploy in a very agile and flexible way,” said Brendan O’Reilly, Group Chief Technology Officer at BAI Communications. “We are delighted to work with Mavenir, a technology innovator company in cloud-native virtualised solutions and a leading player in the Open RAN initiative and 5G Core. Technology we believe will help accelerate Sunderland’s ambitions to become one of the UK’s most advanced smart cities, connecting people, communities and businesses.”
“BAI Communications represents an ideal partner for this prestigious smart city project in Sunderland. Together, we will be able to build new RAN and Packet Core domains that will deliver the flexibility needed for a diverse set of cross-sector use cases. Virtualised solutions from Mavenir are the perfect choice of technology with Open vRAN and Cloud-Native Packet Core. The objective is to automate operations and flex the scalability in neutral hosting architecture, whilst delivering benefits not only to enterprises and business users, but also for the wider community,” said Stefano Cantarelli, Chief Marketing Officer at Mavenir.
“We are creating a new digital fabric for Sunderland’s City, upon which the City’s digital and business entrepreneurs can build – a portfolio of new digital services for the benefits of residents, businesses and visitors,” says Andrew Conway, Director of Solutions and Innovation at BAI Communications UK.
Liz St Louis, Assistant Director of Smart Cities at Sunderland City Council, said, “We have long recognised the importance of technology in connecting people and realising opportunities to position Sunderland as a digital frontrunner. This new partnership between BAI Communications and Mavenir presents a fully scalable network architecture to unlock innovation and shape the future of our leading smart city.
“Together, we are harnessing the power of technology and digital transformation for the benefit of residents, businesses and visitors to Sunderland. The new network will accelerate the emergence of more smart services including community applications, digital upskilling opportunities and efficiency drives for our advanced manufacturing clusters across the city.”
About Mavenir:
Mavenir is building the future of networks and pioneering advanced technology, focusing on the vision of a single, software-based automated network that runs on any cloud. As the industry's only end-to-end, cloud-native network software provider, Mavenir is focused on transforming the way the world connects, accelerating software network transformation for 250+ Communications Service Providers in over 120 countries, which serve more than 50% of the world’s subscribers. www.mavenir.com
About BAI Communications:
BAI Communications is a world leader in shared communications infrastructure, pioneering solutions that empower our customers to advance their services, accelerate their networks and amplify their reach in the most efficient and cost-effective ways possible. Having long been at the forefront of network advancement, BAI is harnessing fibre, spearheading the transition from 4G/LTE, accelerating 5G and preparing for 6G – and beyond. We collaborate closely with our customers in MNOs, government, transit, enterprise, broadcasting and venues to realise their communications vision, focusing not just on the immediate future, but on the possibilities that exist over long-term partnerships. Our global operations span Australia, Canada, Hong Kong, United Kingdom and in the United States through BAI Group company, Mobilitie , and majority-owned Transit Wireless . Together, we’re creating smarter communities for all. https://www.baicommunications.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20220110005089/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom